US Patent Issued to University-Industry Cooperation Group of Kyung Hee University on Sept. 1 for "Virus-like particles containing CST1 protein and toxoplasma vaccine using same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,886, issued on Sept. 1, was assigned to University-Industry Cooperation Group of Kyung Hee University (Yongin-si, South Korea).

"Virus-like particles containing CST1 protein and toxoplasma vaccine using same" was invented by Fu-Shi Quan (Seoul, South Korea), Gi-Deok Eom (Seoul, South Korea), Hae-Ji Kang (Seoul, South Korea), Keon-Woong Yoon (Seoul, South Korea) and Min-Ju Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a Toxoplasma gondii cyst wall protein cst1 (CST1)-containing influenza virus-like particle, which includes a core consisting of an influenza virus matrix protein 1 (M1); and the CST1 protein of Toxo...